Company Legal Name
Latest Valuation
Founded Year
Headquarter
Heidi Health develops AI-powered medical scribe software that automates clinical documentation and electronic health record tasks for outpatient physicians. Founded in 2019 and headquartered in Cremorne, Australia, the company addresses the critical challenge of administrative burden in healthcare by enabling doctors to focus more time on patient care rather than paperwork. Heidi Health has achieved significant market traction in the rapidly growing AI medical scribes sector, reaching a valuation of $465 million. The company continues to expand its automated documentation capabilities, positioning itself as a key player in the digital transformation of healthcare administration and clinical workflow optimization.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
